Ground-level proof points accumulating: management narrates several small, named, recent wins and treats them as the lea
The model's full reasoning — Q4 2022 call → NOWe need to answer YES or NO based on the criteria. The question asks: does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from inside the business, each one identifiable on its own — AND does management explicitly treat these accumulating episodes as the LEADING EDGE of a broader improvement that is still early? We need to check both halves. First, are there at least three distinct, named or individually identifiable episodes from the recent period? The call covers Q4 2022. Management mentions several specific things: e.g., Libtayo approval for non-small cell lung cancer, aflibercept 8 mg BLA submission, Dupixent approvals (prurigo nodularis in Europe, eosinophilic esophagitis), odronextamab data, linvoseltamab data, etc. But these are mostly regulatory approvals, data presentations, and pipeline milestones. Are these "ground-level wins" like specific customers, sites, contracts? The question gives examples: particular customer, account, partner, site, plant, product, region, channel, contract. The call does mention specific events: e.g., "we announced in January, fourth quarter U.S. net sales of $1.5 billion" but that's aggregate. It mentions "the short-term closure of a not-for-profit patient co-pay assistance fund, which reopened later in the quarter" - that's an episode but it's about a problem. It mentions "Libtayo was approved by the FDA in combination with chemotherapy in first-line non-small cell lung cancer" - that's a regulatory approval, not a ground-level win like a customer signing. It mentions "Dupixent was approved for prurigo nodularis in Europe" and "approved for eosinophilic esophagitis" - again approvals. It mentions "we presented data from our rapidly advancing oncology pipeline" - data presentations. It mentions "we have initiated clinical studies for two new drug candidates" - that's a plan/action. The question specifically asks for "individually small, freshly occurred, operator-level facts — the kind of detail only people close to the business would narrate — not aggregate results, percentages, themes, or claims like 'demand was strong across the board.'" The examples given are like a particular customer, site, product shipping first units, etc.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
AU · Q2 2018 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple specific, recent operational episodes: Kibali’s underground ramp-up with automated ore handling system and vertical shaft integration; Iduapriem’s CIL tank conversion and grade/tonnage gains; Sunrise Dam’s Recovery Enhancement Project plus new mining strategies; Tropicana’s second 6-MW ball mill installation; Siguiri’s CIL circuit milestone; and 338 tracked Operational Excellence projects.
BXP · Q1 2022 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple distinct, named episodes from the recent period: the 73,000 sq ft recapture/release at 77 CityPoint with a 15% rent increase and 7.
CRGO · Q1 2024 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...